Chris Pulling

Chris is currently CEO of MicroOptx, Inc. Prior to MicroOptx, Chris was CEO of The Integra Group, a contract medical research organization he founded in 2002, until its recent sale to the world’s largest organization in the medical device sector. At the time of the sale, Integra was assisting over 400 pre-market medical device companies in all aspects of research and development and regulatory affairs. At Integra, Chris was personally involved in over 30 original PMA approvals. Prior to that he was with Medtronic, where he built and ran the Cardiac Rhythm Management’s clinical biostatistics group. Chris has three U.S. patents filed or pending. Chris has a BA in Mathematics from Hamline University and an MS in Biostatistics from the University of Minnesota.